{"id":"511","presentation":"262 - Impact of Residual Secondary Mitral Regurgitation on Clinical Outcomes after LVAD Implantation: An Analysis from the MOMENTUM 3 Pivotal Trial and Continuous Access Protocol Study","session":"SESSION 71 - ORAL: Valve Regurgitation in MCS Patients","filename":"MOMENTUM 3 MR ISHLT_FINAL.pptx","speaker":"M. Mehra<small>, Pittsburgh, PA, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/511\/jpg\/momentum3mrishlt_final\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/6411cbe476a949a116304ffd42ec670e","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]